Pfizer and BioNTech Seek Vaccine Approval for Those Ages 12-15

Veuer 2021-12-17

Views 1

A successful Phase 3 clinical trial has led to the Pfizer and BioNTech to seek full vaccine approval for people between 12 and 15 years-old. Veuer’s Maria Mercedes Galuppo has the story.

Share This Video


Download

  
Report form
RELATED VIDEOS